​As of 3 October, wild-type poliovirus 1 (WPV1) was still being isolated in wastewater treatment plants across the country with some areas indicating an inconsistent or discontinued detection. However, no new sites in Israel with WPV1 in sewage were detected since the start of the bivalent oral polio vaccine (bOPV) immunisation campaign, according to personal communication from the Ministry of Health in Israel.

​Ten of the 22 acute flaccid paralysis (AFP) cases in the Syrian Arab Republic suspected of being caused by wild poliovirus have been confirmed as wild poliovirus type 1 (WPV1) by the World Health Organization (WHO).

​On 6 November 2013, Public Health Authorities in French Polynesia reported of an outbreak of sub-febrile and eruptive syndrome due to Zika virus spreading across the archipelago since week 41 of 2013. An outbreak of dengue type 1 and 3 is on-going in the archipelago since February 2013.

​The Hellenic Centre for Disease Control and Prevention (KEELPNO) has reported three autochthonous cases of Plasmodium vivax malaria up to 16 November 2013.

​In March 2013, Chinese authorities announced the identification of a novel reassortant A(H7N9) avian influenza virus in patients in eastern China.

​An outbreak of chikungunya in the Caribbean region was reported from the French part of the island of Saint Martin on 5 December 2013.

​In March 2013, Chinese authorities announced the identification of a novel reassortant A(H7N9) influenza virus in patients in eastern China. Since then, human cases have continued to be reported, and as of 7 February 2014 (Figure 1), there have been 308 laboratory-confirmed cases: Zhejiang (122), Guangdong (54), Shanghai (42), Jiangsu (36), Fujian (19), Hunan (7), Jiangxi (5), Henan (4), Anhui (4) ,Beijing (3), Shandong (2), Hebei (1), Guangxi (2), Guizhou (1), Hong Kong (4) and Taiwan (2). In addition, the virus has been detected in one asymptomatic case in Beijing.